Cipla Docks Into China With Manufacturing Plans In Tow

 
• By Anju Ghangurde

More Indian companies are headed to China, with Cipla the latest to seal a joint venture there, though the firm has previous links with the country. Respiratory products will lead Cipla’s line-up in China, a market seen as a crucial cog in the firm’s future road map.

China - India
Cipla Firms Up China JV • Source: Shutterstock

Cipla Ltd. has joined the growing list of Indian pharma companies docking firmly into China to tap into emerging opportunities in the world’s second-largest pharmaceutical market.

Cipla’s UK-based arm Cipla (EU) Ltd. has formed an 80:20 joint venture with Jiangsu Acebright Pharmaceutical Co. Ltd. for the China market, with a combined investment of $30m

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Generics Bulletin